Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kleopatra Rapti

Showing results (1-10 of 33) with videos related to

Pageof 4
Sort By:
Frontiers in Immunology|November 15, 2021
Adeno-Associated Viruses (AAV) and Host Immunity - A Race Between the Hare and the HedgehogKleopatra Rapti, Dirk Grimm
Gene Therapy|March 18, 2025
AAV vector engineering for human aorta transduction: becoming a smooth operatorKleopatra Rapti, Dirk Grimm
Methods in Molecular Biology (Clifton, N.J.)|December 3, 2016
Cell-Based Measurement of Neutralizing Antibodies Against Adeno-Associated Virus (AAV)Andreas Jungmann, Oliver Müller, Kleopatra Rapti
The Canadian Journal of Cardiology|May 24, 2011
Targeted gene therapy for the treatment of heart failureKleopatra Rapti, Antoine H Chaanine, Roger J Hajjar
Molecular Therapy. Methods & Clinical Development|June 9, 2015
Effectiveness of gene delivery systems for pluripotent and differentiated cellsKleopatra Rapti, Francesca Stillitano, Ioannis Karakikes, et al.
Journal of Molecular and Cellular Cardiology|March 1, 2005
Alterations in the heart mitochondrial proteome in a desmin null heart failure modelMichael Fountoulakis, Elisavet Soumaka, Kleopatra Rapti, et al.
Free Radical Biology & Medicine|June 21, 2017
Opposite effects of catalase and MnSOD ectopic expression on stress induced defects and mortality in the desmin deficient cardiomyopathy modelKleopatra Rapti, Antigoni Diokmetzidou, Ismini Kloukina, et al.
Viruses|February 26, 2022
Induction of Hepatitis E Virus Anti-ORF3 Antibodies from Systemic Administration of a Muscle-Specific Adeno-Associated Virus (AAV) VectorLars Maurer, Jihad El Andari, Kleopatra Rapti, et al.
Human Gene Therapy Methods|July 24, 2012
Quantification of AAV particle titers by infrared fluorescence scanning of coomassie-stained sodium dodecyl sulfate-polyacrylamide gelsErik Kohlbrenner, Els Henckaerts, Kleopatra Rapti, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|September 15, 2011
Neutralizing antibodies against AAV serotypes 1, 2, 6, and 9 in sera of commonly used animal modelsKleopatra Rapti, Vedell Louis-Jeune, Erik Kohlbrenner, et al.
Pageof 4

Showing results (1-10 of 33) with videos related to

Sort By:
Pageof 4
Frontiers in Immunology|November 15, 2021
Adeno-Associated Viruses (AAV) and Host Immunity - A Race Between the Hare and the HedgehogKleopatra Rapti, Dirk Grimm
Gene Therapy|March 18, 2025
AAV vector engineering for human aorta transduction: becoming a smooth operatorKleopatra Rapti, Dirk Grimm
Methods in Molecular Biology (Clifton, N.J.)|December 3, 2016
Cell-Based Measurement of Neutralizing Antibodies Against Adeno-Associated Virus (AAV)Andreas Jungmann, Oliver Müller, Kleopatra Rapti
The Canadian Journal of Cardiology|May 24, 2011
Targeted gene therapy for the treatment of heart failureKleopatra Rapti, Antoine H Chaanine, Roger J Hajjar
Molecular Therapy. Methods & Clinical Development|June 9, 2015
Effectiveness of gene delivery systems for pluripotent and differentiated cellsKleopatra Rapti, Francesca Stillitano, Ioannis Karakikes, et al.
Journal of Molecular and Cellular Cardiology|March 1, 2005
Alterations in the heart mitochondrial proteome in a desmin null heart failure modelMichael Fountoulakis, Elisavet Soumaka, Kleopatra Rapti, et al.
Free Radical Biology & Medicine|June 21, 2017
Opposite effects of catalase and MnSOD ectopic expression on stress induced defects and mortality in the desmin deficient cardiomyopathy modelKleopatra Rapti, Antigoni Diokmetzidou, Ismini Kloukina, et al.
Viruses|February 26, 2022
Induction of Hepatitis E Virus Anti-ORF3 Antibodies from Systemic Administration of a Muscle-Specific Adeno-Associated Virus (AAV) VectorLars Maurer, Jihad El Andari, Kleopatra Rapti, et al.
Human Gene Therapy Methods|July 24, 2012
Quantification of AAV particle titers by infrared fluorescence scanning of coomassie-stained sodium dodecyl sulfate-polyacrylamide gelsErik Kohlbrenner, Els Henckaerts, Kleopatra Rapti, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|September 15, 2011
Neutralizing antibodies against AAV serotypes 1, 2, 6, and 9 in sera of commonly used animal modelsKleopatra Rapti, Vedell Louis-Jeune, Erik Kohlbrenner, et al.
Pageof 4